Novo Nordisk AS
(HAM:NOVA)
€
41.8
-0.20 (-0.48%)
Market Cap: 185.04 Bil
Enterprise Value: 201.74 Bil
PE Ratio: 11.60
PB Ratio: 6.95
GF Score: 81/100 Novo Nordisk A/S Virtual R&D Investor Presentation Transcript
Jun 19, 2020 / 01:00PM GMT
Karsten Munk Knudsen;S;Executive VP
Novo Nordisk A;CFO & Member of the Management Board
/- -
Ladies and gentlemen, welcome to the Novo Nordisk R&D Investor Event. We've been looking forward to this event. As you know that over the past number of weeks we've had some really exciting pipeline readouts. So today, we have the opportunity to go into greater details on the trial readouts we just had.
With me today, I have our Chief Science Officer, Mads Krogsgaard Thomsen, our
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot